Create
Log in
Sign up
Golden has been acquired by ComplyAdvantage.
Read about it here ⟶
Sharon Wen
Overview
Structured Data
Issues
Contributors
Activity
All edits
Edits on 14 Dec, 2021
"Remove inverse infobox"
Golden AI
edited on 14 Dec, 2021
Edits made to:
Infobox
(
-40
properties)
Infobox
Patent primary examiner of
US Patent 7816498 Monoclonal antibody for hippuric acid antigen
US Patent 7847066 Antibody that binds uridine diphosphate
US Patent 7854942 Anti-gluten egg yolk antibodies for the treatment of celiac disease
US Patent 7858758 Monoclonal antibodies for detection of urinary trypsin inhibitors
US Patent 7868152 Polynucleotides encoding anti-sulfotyrosine antibodies
US Patent 7872106 Sclerostin-binding antibodies
US Patent 7888482 Antibodies that bind PAR-2
US Patent 7888483 Antagonists of protease activated receptor-1 (PAR1)
US Patent 7888486 Antagonist antibodies against GDF-8
US Patent 7893218 Antibodies that specifically bind SOST peptides
US Patent 7901679 Humanized anti-ghrelin antibodies
US Patent 7901900 Assay kit and antibody for human low molecular weight CD14
US Patent 7902340 Antibodies binding to the extracellular domain of the receptor tyrosine kinase ALK
US Patent 7910107 Antagonist antibodies against GDF-8 and uses in treatment of ALS and other GDF-8 associated disorders
US Patent 7915391 Humanized c-Kit antibody
US Patent 7919089 Pharmaceutical composition comprising a bispecific antibody for EpCAM
US Patent 7927592 Method of inhibiting complement activation
US Patent 7932363 Antibody that binds human eosinophil-derived basic protein
US Patent 7935502 Hepatocyte growth factor (HGF) binding proteins
US Patent 7935792 Antibody reacting with N-acetylglucosamine-6-O-sulfotransferase product
US Patent 7935796 Monoclonal antibodies against ANGPTL3
US Patent 7943344 Hepatocyte growth factor (HGF) binding proteins
US Patent 7947811 Antibodies that bind specifically to human RON protein
US Patent 7951779 Method of protecting cells against damage and pharmaceutical composition comprising leumorphin
US Patent 7959919 Method of inhibiting factor B-mediated complement activation
US Patent 7959920 Methods of making and using antibodies directed to parathyroid hormone
US Patent 7968689 Antibodies to HSDEK49 polypeptides
US Patent 7972599 Immunomodulation of inflammatory conditions utilizing Follistatin-like protein-1 and agents that bind thereto
US Patent 7972785 Biomarkers for liver fibrotic injury
US Patent 7973142 Antibodies that bind human protein tyrosine phosphatase beta (HPTPβ)
US Patent 7973143 Sphingosine-1-phosphate lyase polypeptides, polynucleotides and modulating agents and methods of use therefor
US Patent 7985844 Antibody that specifically binds hyaluronan synthase
US Patent 7993646 HK1-binding proteins
US Patent 7994293 Antibodies specific for Dkk-1
US Patent 7994294 Nucleic acids and polypeptides related to a guanine exchange factor of Rho GTPase
US Patent 8007798 Treatment of complement-associated disorders
US Patent 8007804 Complement receptor 2 targeted complement modulators
US Patent 8008452 Phosphorylated Ndr kinase
US Patent 8012483 Phosphorylcholine conjugates and corresponding antibodies
US Patent 8013116 Therapeutic peptides and method
Edits on 13 Dec, 2021
Golden AI
edited on 13 Dec, 2021
Edits made to:
Infobox
(
+1
properties)
Infobox
Patent primary examiner of
US Patent 8013116 Therapeutic peptides and method
Golden AI
edited on 13 Dec, 2021
Edits made to:
Infobox
(
+1
properties)
Infobox
Patent primary examiner of
US Patent 8012483 Phosphorylcholine conjugates and corresponding antibodies
Edits on 8 Dec, 2021
Golden AI
edited on 8 Dec, 2021
Edits made to:
Infobox
(
+1
properties)
Infobox
Patent primary examiner of
US Patent 8008452 Phosphorylated Ndr kinase
Golden AI
edited on 8 Dec, 2021
Edits made to:
Infobox
(
+1
properties)
Infobox
Patent primary examiner of
US Patent 8007804 Complement receptor 2 targeted complement modulators
Golden AI
edited on 8 Dec, 2021
Edits made to:
Infobox
(
+1
properties)
Infobox
Patent primary examiner of
US Patent 8007798 Treatment of complement-associated disorders
Golden AI
edited on 8 Dec, 2021
Edits made to:
Infobox
(
+1
properties)
Infobox
Patent primary examiner of
US Patent 7994294 Nucleic acids and polypeptides related to a guanine exchange factor of Rho GTPase
Golden AI
edited on 8 Dec, 2021
Edits made to:
Infobox
(
+1
properties)
Infobox
Patent primary examiner of
US Patent 7994293 Antibodies specific for Dkk-1
Golden AI
edited on 8 Dec, 2021
Edits made to:
Infobox
(
+1
properties)
Infobox
Patent primary examiner of
US Patent 7993646 HK1-binding proteins
Golden AI
edited on 8 Dec, 2021
Edits made to:
Infobox
(
+1
properties)
Infobox
Patent primary examiner of
US Patent 7985844 Antibody that specifically binds hyaluronan synthase
Golden AI
edited on 8 Dec, 2021
Edits made to:
Infobox
(
+1
properties)
Infobox
Patent primary examiner of
US Patent 7973143 Sphingosine-1-phosphate lyase polypeptides, polynucleotides and modulating agents and methods of use therefor
Golden AI
edited on 8 Dec, 2021
Edits made to:
Infobox
(
+1
properties)
Infobox
Patent primary examiner of
US Patent 7973142 Antibodies that bind human protein tyrosine phosphatase beta (HPTPβ)
Golden AI
edited on 8 Dec, 2021
Edits made to:
Infobox
(
+1
properties)
Infobox
Patent primary examiner of
US Patent 7972785 Biomarkers for liver fibrotic injury
Golden AI
edited on 8 Dec, 2021
Edits made to:
Infobox
(
+1
properties)
Infobox
Patent primary examiner of
US Patent 7972599 Immunomodulation of inflammatory conditions utilizing Follistatin-like protein-1 and agents that bind thereto
Golden AI
edited on 8 Dec, 2021
Edits made to:
Infobox
(
+1
properties)
Infobox
Patent primary examiner of
US Patent 7968689 Antibodies to HSDEK49 polypeptides
Edits on 7 Dec, 2021
Golden AI
edited on 7 Dec, 2021
Edits made to:
Infobox
(
+1
properties)
Infobox
Patent primary examiner of
US Patent 7959920 Methods of making and using antibodies directed to parathyroid hormone
Golden AI
edited on 7 Dec, 2021
Edits made to:
Infobox
(
+1
properties)
Infobox
Patent primary examiner of
US Patent 7959919 Method of inhibiting factor B-mediated complement activation
Golden AI
edited on 7 Dec, 2021
Edits made to:
Infobox
(
+1
properties)
Infobox
Patent primary examiner of
US Patent 7951779 Method of protecting cells against damage and pharmaceutical composition comprising leumorphin
Golden AI
edited on 7 Dec, 2021
Edits made to:
Infobox
(
+1
properties)
Infobox
Patent primary examiner of
US Patent 7947811 Antibodies that bind specifically to human RON protein
Golden AI
edited on 7 Dec, 2021
Edits made to:
Infobox
(
+1
properties)
Infobox
Patent primary examiner of
US Patent 7943344 Hepatocyte growth factor (HGF) binding proteins
Load more
Find more people like Sharon Wen
Use the Golden Query Tool to discover related individuals, professionals, or experts with similar interests, expertise, or connections in the Knowledge Graph.
Open Query Tool
Access by API
Company
Home
Press & Media
Blog
Careers
WE'RE HIRING
Products
Knowledge Graph
Query Tool
Data Requests
Knowledge Storage
API
Pricing
Enterprise
ChatGPT Plugin
Legal
Terms of Service
Enterprise Terms of Service
Privacy Policy
Help
Help center
API Documentation
Contact Us
SUBSCRIBE